Research and development
A global
R&D
program
Research and development
More than 4,000 independent, peer-reviewed research papers have now been published on the bioactive properties of fucoidans. This extensive body of evidence includes comprehensive in vitro investigations, animal studies and human clinical trials. The vast majority of this research has been conducted in the last 20 years, with Marinova leading the way.
With state-of-the-art laboratories and a team of distinguished scientists, Marinova continues to develop novel fucoidan extracts with enhanced bioactivity. An extensive range of assays, commercial scale-up and quality testing are all undertaken in-house. In addition to the company’s own expertise, Marinova has an established global research network and collaborates with leading research institutions to undertake human clinical trials.
Marinova’s active research and development program continues to focus largely on the five key areas identified below.
- Immune modulation
+ read more - Gut & digestive health
+ read more - Integrative oncology
+ read more - Anti-inflammation
+ read more - Skincare & dermal health
+ read more
Custom extracts
Marinova has the expertise and capability to develop and produce high purity fucoidan fractions for a wide range of advanced applications. We are experienced in creating novel compounds for very specific purposes, from biomaterials research through to medical device applications and pharmaceutical development.
Research samples
Marinova is the leading resource for species-specific fucoidan extracts for research and analysis. We are also the leading supplier of reference samples to formulators in the nutritional and personal care sectors who may be seeking to verify the quality and purity specifications of generic fucoidan extracts.
To find out more about Marinova's fucoidan extracts please contact us.